Successive intraocular nocardiosis and cytomegalovirus retinitis after cardiac transplantation.
Chaudhry
N A
NA
Tabandeh
H
H
Davis
J
J
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000601:surgery; D015377:Cilastatin / Q000627:therapeutic use; D017726:Cytomegalovirus Retinitis / Q000150:complications* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000150:complications* / Q000188:drug therapy; D015774:Ganciclovir / Q000627:therapeutic use; D016027:Heart Transplantation; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use; D008297:Male; D009617:Nocardia Infections / Q000150:complications* / Q000188:drug therapy; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy; D011480:Protease Inhibitors / Q000627:therapeutic use; D012173:Retinitis / Q000150:complications* / Q000188:drug therapy; D013845:Thienamycins / Q000627:therapeutic use
D000998:Antiviral Agents; D011480:Protease Inhibitors; D013845:Thienamycins; D015377:Cilastatin; D015378:Imipenem; D015774:Ganciclovir